RAF1 mutation leading to hypertrophic cardiomyopathy in a Chinese family with a history of sudden cardiac death: A diagnostic insight into Noonan syndrome

被引:1
|
作者
Zheng, Jingjing [1 ,2 ]
Peng, Longyun [3 ]
Cheng, Ruofei [1 ,2 ]
Li, Zhiyan [1 ,2 ]
Xie, Jianjie [1 ,2 ]
Huang, Erwen [1 ,2 ]
Cheng, Jianding [1 ,2 ]
Zhao, Qianhao [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Fac Forens Med, Zhongshan Sch Med, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Guangdong Prov Translat Forens Med Engn Technol Re, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Peoples R China
来源
MOLECULAR GENETICS & GENOMIC MEDICINE | 2024年 / 12卷 / 01期
基金
中国国家自然科学基金;
关键词
hypertrophic cardiomyopathy; Noonan syndrome; RAF1; gene; RAS-HCM; whole-exome sequencing; OF-FUNCTION MUTATIONS; RARE VARIANTS; PHENOTYPE; SPECTRUM; OUTCOMES;
D O I
10.1002/mgg3.2290
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Hypertrophic cardiomyopathy (HCM) is predominantly caused by mutations in sarcomeric genes. However, a subset of cases is attributed to genetic disorders unrelated to sarcomeric genes, such as Noonan syndrome (NS) and other RASopathies. In this study, we present a family with a history of sudden cardiac death (SCD) and focus on two adults with syndromic left ventricular hypertrophy (LVH).Methods; Clinical evaluations, including echocardiography, were conducted to assess cardiac manifestations. Whole-exome sequencing was performed to identify potential genetic variants underlying syndromic LVH in the study participants.Results: Whole-exome sequencing revealed a missense variant in the RAF1 gene, c.782C>T (p.Pro261Leu). This variant confirmed the diagnosis of NS in the affected individuals.Conclusion: The findings of this study underscore the importance of family history investigation and genetic testing in diagnosing syndromic LVH. By identifying the underlying genetic cause, clinicians can better understand the etiology of RAS-HCM and its association with SCD in young adults.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Validation of the Risk Stratification for Sudden Cardiac Death in Chinese Patients With Hypertrophic Cardiomyopathy
    Qi, Weitang
    Pu, Lutong
    Zhang, Jinquan
    Chen, Hongyu
    Tang, Zihuan
    Wang, Jie
    Han, Yuchi
    Chen, Yucheng
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (11)
  • [22] Molecular autopsy and clinical family screening in a case of sudden cardiac death reveals ACTN2 mutation related to hypertrophic/dilated cardiomyopathy and a novel LZTR1 variant associated with Noonan syndrome
    Kraoua, Lilia
    Jaouadi, Hager
    Allouche, Mohamed
    Achour, Ahlem
    Kaouther, Hakim
    Ben Ahmed, Habib
    Chaker, Lilia
    Maazoul, Faouzi
    Ouarda, Fatma
    Zaffran, Stephane
    M'rad, Ridha
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2022, 10 (07):
  • [23] Neonatal Pulmonary Arterial Hypertension and Noonan Syndrome: Two Fatal Cases with a Specific RAF1 Mutation
    Hopper, Rachel K.
    Feinstein, Jeffrey A.
    Manning, Melanie A.
    Benitz, William
    Hudgins, Louanne
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2015, 167 (04) : 882 - 885
  • [24] LMNA Mutation in a Family with a Strong History of Sudden Cardiac Death
    Keil, Laura
    Berisha, Filip
    Knappe, Dorit
    Kubisch, Christian
    Shoukier, Moneef
    Kirchhof, Paulus
    Fabritz, Larissa
    Hellenbroich, Yorck
    Woitschach, Rixa
    Magnussen, Christina
    GENES, 2022, 13 (02)
  • [25] Strain- induced Cardiac Arrhythmias Caused By A Noonan Syndrome Mutation In Raf1 Can Be Suppressed By Modulation Of The Rasmapk Pathway In Vitro
    Haghighi, Fereshteh
    Boehmker, Leonie
    Liutkute, Aiste
    Kleemann, Karolin
    Busley, Alexandra V.
    Pietras, Jan P.
    Fakaude, Funsho E.
    Seibertz, Fitzwilliam
    Rubio, Tony
    Kutschka, Ingo
    Zenker, Martin
    Voigt, Niels
    Cyganek, Lukas
    Kensah, George
    CIRCULATION RESEARCH, 2023, 133
  • [26] Generation of Raf1 Mutant and Crispr-cas9 Corrected Isogenic iPSC-derived Cardiomyocytes to Model Hypertrophic Cardiomyopathy in Noonan Syndrome
    Jaffre, Fabrice
    Wang, Gang
    Roberts, Amy
    Pu, William
    Hahn, Andreas
    Kontaridis, Maria
    CIRCULATION RESEARCH, 2015, 117
  • [27] Role of Family History of Sudden Death in Risk Stratification and Prevention of Sudden Death With Implantable Defibrillators in Hypertrophic Cardiomyopathy
    Bos, J. Martijn
    Maron, Barry J.
    Ackerman, Michael J.
    Haas, Tammy S.
    Sorajja, Paul
    Nishimura, Rick A.
    Gersh, Bernard J.
    Ommen, Steve R.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (10): : 1481 - 1486
  • [28] The yield of cardiac screening and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers
    Michels, M.
    Hoedemaekers, Y. M.
    Kofflard, M. J.
    Soliman, O. I. I.
    Dooijes, D.
    Majoor-Krakauer, D.
    Ten Cate, F. J.
    EUROPEAN HEART JOURNAL, 2007, 28 : 473 - 473
  • [29] Impact of positive family history on personal risk of sudden death for patients with hypertrophic cardiomyopathy
    Sorajja, P
    Ackerman, MJ
    Gersh, BJ
    Shen, WK
    Nishimura, RA
    Ommen, SR
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 43A - 43A
  • [30] Re-examining family history of sudden death as a risk marker in hypertrophic cardiomyopathy
    Siontis, Konstantinos C.
    Ommen, Steven R.
    Maron, Martin S.
    Maron, Barry J.
    HEART RHYTHM, 2024, 21 (10) : 1838 - 1842